Walsworth Publishes 2020 Life Sciences Year In Review
Walsworth publishes its 2020 Year In Review Life Sciences Update. Stay up-to-date with our discussion of recent drug litigation, including Lipitor and Lexapro, device litigation, including pelvis mesh and breast implants, talc, opioids, and trends in life sciences, including CBD, COVID-19 updates and trials, and pending U.S. Supreme Court jurisdictional litigation.
Click here to read the full report.
For more information, please contact Lisa Rice, Laurie Sherwood, Katie Stricklin or Amrit Dhaliwal.